Historic Gene Therapy Milestone for Cockayne Syndrome Carries Implications for Hearing Loss Community
A 6-year-old boy with Cockayne syndrome — a rare genetic disorder that causes hearing loss, vision impairment, and early death — has become the first child to receive an experimental AAV9 gene therapy developed through a parent-led initiative.